JPY 3455.0
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 28.44 Billion | 29.48 Billion | 29.73 Billion | 25.04 Billion | 26.19 Billion |
Cost of Revenue | 24.11 Billion | 25.07 Billion | 25.17 Billion | 21.44 Billion | 22.49 Billion |
Gross Profit | 4.33 Billion | 4.4 Billion | 4.55 Billion | 3.59 Billion | 3.7 Billion |
Operating Expenses | 2.82 Billion | 2.71 Billion | 2.58 Billion | 2.32 Billion | 2.32 Billion |
Selling, General and Administrative Expenses | 2.82 Billion | 2.71 Billion | 2.58 Billion | 2.32 Billion | 2.37 Billion |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 1 Million | 48.32 Million | 60.74 Million | 71.76 Million | - |
Cost and Expenses | 26.93 Billion | 27.78 Billion | 27.75 Billion | 23.76 Billion | 24.82 Billion |
Operating Income | 1.51 Billion | 1.69 Billion | 1.97 Billion | 1.27 Billion | 1.32 Billion |
Interest Expense | - | - | 3.81 Million | 3.12 Million | - |
Income Tax Expense | 539 Million | 668.47 Million | 640.92 Million | 435.37 Million | 462 Million |
Earnings before Tax | 1.61 Billion | 2.09 Billion | 2.06 Billion | 1.38 Billion | 1.43 Billion |
Net Income | 1.07 Billion | 1.42 Billion | 1.42 Billion | 949.21 Million | 972 Million |
Earnings Per Share Basic | 264.88 | 340.14 | 330.69 | 219.41 | 224.87 |
Earnings Per Share Diluted | 264.69 | 339.83 | 330.58 | 219.41 | 224.87 |
Weighted Average Shares Outstanding | 4.05 Million | 4.2 Million | 4.3 Million | 4.32 Million | 4.32 Million |
Weighted Average Shares Outstanding (Diluted) | 4.06 Million | 4.2 Million | 4.3 Million | 4.32 Million | 4.32 Million |
Gross Margin | 0.15 | 0.15 | 0.15 | 0.14 | 0.14 |
EBIT Margin | 0.06 | 0.05 | 0.07 | 0.06 | 0.05 |
Profit Margin | 0.04 | 0.05 | 0.05 | 0.04 | 0.04 |
EBITDA | 1.76 Billion | 1.77 Billion | 2.11 Billion | 1.42 Billion | 1.37 Billion |
Earnings Before Tax Margin | 0.05 | 0.06 | 0.07 | 0.05 | 0.05 |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 7.04 Billion | 28.44 Billion | 7.09 Billion | 7.54 Billion | 7.15 Billion | 6.65 Billion |
Cost of Revenue | 6.02 Billion | 24.11 Billion | 5.94 Billion | 6.41 Billion | 6.08 Billion | 5.66 Billion |
Gross Profit | 1.01 Billion | 4.33 Billion | 1.15 Billion | 1.13 Billion | 1.06 Billion | 980.34 Million |
Operating Expenses | 724 Million | 2.82 Billion | 811.29 Million | 694.28 Million | 655.7 Million | 662.35 Million |
Selling, General and Administrative Expenses | 724 Million | - | 811 Million | 694 Million | 656 Million | 662 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 35.64 Million | 6.37 Million | 10.98 Million | 6.34 Million | 11.95 Million |
Cost and Expenses | 6.74 Billion | 26.93 Billion | 6.75 Billion | 7.1 Billion | 6.74 Billion | 6.33 Billion |
Operating Income | 291 Million | 1.51 Billion | 341.9 Million | 441.9 Million | 413.19 Million | 317.99 Million |
Interest Expense | - | - | - | - | - | - |
Income Tax Expense | 110 Million | 539 Million | 142.69 Million | 151.11 Million | 135.06 Million | 110.12 Million |
Earnings before Tax | 339 Million | 1.61 Billion | 362.05 Million | 468.8 Million | 432.81 Million | 350.1 Million |
Net Income | 229 Million | 1.07 Billion | 219.36 Million | 317.69 Million | 297.74 Million | 239.97 Million |
Earnings Per Share Basic | 57.47 | - | 54.71 | 78.65 | 72.98 | 58.57 |
Earnings Per Share Diluted | 57.47 | - | 54.69 | 78.65 | 72.98 | 58.57 |
Weighted Average Shares Outstanding | 3.98 Million | 4.05 Million | 4 Million | 4.04 Million | 4.08 Million | 4.09 Million |
Weighted Average Shares Outstanding (Diluted) | 3.98 Million | 4.06 Million | 4.01 Million | 4.04 Million | 4.08 Million | 4.09 Million |
Gross Margin | 0.14 | 0.15 | 0.16 | 0.15 | 0.15 | 0.15 |
EBIT Margin | 0.05 | - | 0.05 | 0.06 | 0.06 | 0.05 |
Profit Margin | 0.03 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 |
EBITDA | 329.5 Million | - | 348.82 Million | 441.9 Million | 413.19 Million | 317.99 Million |
Earnings Before Tax Margin | 0.04 | 0.05 | 0.05 | 0.06 | 0.06 | 0.05 |
NSIT
EFG
AVA
NHIQ
KTWIF
AJANTPHARM